These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 1855195)
1. Distinct patterns of phorbol ester-induced downregulation of protein kinase C activity in adriamycin-selected multidrug resistant and parental murine fibrosarcoma cells. Ward NE; O'Brian CA Cancer Lett; 1991 Jul; 58(3):189-93. PubMed ID: 1855195 [TBL] [Abstract][Full Text] [Related]
2. Transient enhancement of multidrug resistance by the bile acid deoxycholate in murine fibrosarcoma cells in vitro. O'Brian CA; Fan D; Ward NE; Dong Z; Iwamoto L; Gupta KP; Earnest LE; Fidler IJ Biochem Pharmacol; 1991 Mar; 41(5):797-806. PubMed ID: 1998534 [TBL] [Abstract][Full Text] [Related]
3. Expression, subcellular distribution and response to phorbol esters of protein kinase C (PKC) isozymes in drug-sensitive and multidrug-resistant KB cells evidence for altered regulation of PKC-alpha. Cloud-Heflin BA; McMasters RA; Osborn MT; Chambers TC Eur J Biochem; 1996 Aug; 239(3):796-804. PubMed ID: 8774728 [TBL] [Abstract][Full Text] [Related]
4. A novel N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to adriamycin. O'Brian CA; Ward NE; Liskamp RM; de Bont DB; Earnest LE; van Boom JH; Fan D Invest New Drugs; 1991 May; 9(2):169-79. PubMed ID: 1874600 [TBL] [Abstract][Full Text] [Related]
5. Selection and preliminary characterization of variant lines of a murine macrophage tumor resistant to the antiproliferative effects of phorbol esters. Goode NT; Moore JP; Hart IR Cancer Res; 1990 Mar; 50(5):1510-5. PubMed ID: 2105841 [TBL] [Abstract][Full Text] [Related]
6. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate. Schwartz GK; Arkin H; Holland JF; Ohnuma T Cancer Res; 1991 Jan; 51(1):55-61. PubMed ID: 1824824 [TBL] [Abstract][Full Text] [Related]
7. In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells. Dong ZY; Ward NE; Fan D; Gupta KP; O'Brian CA Mol Pharmacol; 1991 Apr; 39(4):563-9. PubMed ID: 2017156 [TBL] [Abstract][Full Text] [Related]
8. Partial characterization of epidermal protein kinase C in mice sensitive or resistant to phorbol ester. Hirabayashi N; Warren BS; Wang XJ; Petersen-Marht S; Beltran L; Davis MM; Ashendel CL; DiGiovanni J Mol Carcinog; 1990; 3(3):171-80. PubMed ID: 2372371 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase C in adriamycin action and resistance in mouse sarcoma 180 cells. Posada J; Vichi P; Tritton TR Cancer Res; 1989 Dec; 49(23):6634-9. PubMed ID: 2819714 [TBL] [Abstract][Full Text] [Related]
10. Retention of vital dyes correlates inversely with the multidrug-resistant phenotype of adriamycin-selected murine fibrosarcoma variants. Bucana CD; Giavazzi R; Nayar R; O'Brian CA; Seid C; Earnest LE; Fan D Exp Cell Res; 1990 Sep; 190(1):69-75. PubMed ID: 2387329 [TBL] [Abstract][Full Text] [Related]
11. Overproduction of the beta 1 form of protein kinase C enhances phorbol ester induction of glucose transporter mRNA. Mountjoy KG; Housey GM; Flier JS Mol Endocrinol; 1989 Dec; 3(12):2018-27. PubMed ID: 2628736 [TBL] [Abstract][Full Text] [Related]
12. Protein kinase C levels and protein phosphorylation associated with inhibition of proliferation in a murine macrophage tumor. Goode NT; Hart IR J Cell Physiol; 1990 Mar; 142(3):480-7. PubMed ID: 2312612 [TBL] [Abstract][Full Text] [Related]
13. Role of phorbol ester receptors in the 12-0-tetradecanoyl-phorbol-13-acetate (TPA)-induced down-regulation of colony-stimulating factor (CSF-1) binding to murine peritoneal exudate macrophages. Chen BD; Wilkins KL J Cell Physiol; 1985 Aug; 124(2):305-12. PubMed ID: 3876342 [TBL] [Abstract][Full Text] [Related]
14. Potent induction of human colon cancer cell uptake of chemotherapeutic drugs by N-myristoylated protein kinase C-alpha (PKC-alpha) pseudosubstrate peptides through a P-glycoprotein-independent mechanism. Bergman PJ; Gravitt KR; Ward NE; Beltran P; Gupta KP; O'Brian CA Invest New Drugs; 1997; 15(4):311-8. PubMed ID: 9547673 [TBL] [Abstract][Full Text] [Related]
15. Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cells. O'Brian CA; Fan D; Ward NE; Seid C; Fidler IJ FEBS Lett; 1989 Mar; 246(1-2):78-82. PubMed ID: 2707442 [TBL] [Abstract][Full Text] [Related]
16. Response of Jurkat T cells to phorbol ester and bryostatin. Development of sublines with distinct functional responses and changes in protein kinase C activity. Levine BL; May WS; Tyler PG; Hess AD J Immunol; 1991 Nov; 147(10):3474-81. PubMed ID: 1834742 [TBL] [Abstract][Full Text] [Related]
17. Differential responsiveness to phorbol esters correlates with differential expression of protein kinase C in KG-1 and KG-1a human myeloid leukemia cells. Hooper WC; Abraham RT; Ashendel CL; Woloschak GE Biochim Biophys Acta; 1989 Sep; 1013(1):47-54. PubMed ID: 2790038 [TBL] [Abstract][Full Text] [Related]
18. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx. Drew L; Groome N; Warr JR; Rumsby MG Oncol Res; 1996; 8(6):249-57. PubMed ID: 8895200 [TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of human melanoma-derived cells by 12-O-tetradecanoyl phorbol 13-acetate. Arita Y; O'Driscoll KR; Weinstein IB Int J Cancer; 1994 Jan; 56(2):229-35. PubMed ID: 8314307 [TBL] [Abstract][Full Text] [Related]
20. Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin. Ahmad S; Trepel JB; Ohno S; Suzuki K; Tsuruo T; Glazer RI Mol Pharmacol; 1992 Dec; 42(6):1004-9. PubMed ID: 1362242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]